Understanding and Communicating the Benefits and Risks of Denosumab, Raloxifene, and Teriparatide for the Treatment of Osteoporosis
- Resource Type
- Review Article
- Source
- In
Journal of Clinical Densitometry October 2014 17(4):490-495 - Subject
- Language
- ISSN
- 1094-6950